Out‐of‐pocket costs of biologic treatments for chronic rhinosinusitis with nasal polyposis in the Medicare population
Gespeichert in:
Veröffentlicht in: | International forum of allergy & rhinology 2022-10, Vol.12 (10), p.1295-1298 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1298 |
---|---|
container_issue | 10 |
container_start_page | 1295 |
container_title | International forum of allergy & rhinology |
container_volume | 12 |
creator | Rathi, Vinay K. Scangas, George A. Metson, Ralph B. Xiao, Roy Nshuti, Leonce Dusetzina, Stacie B. |
description | |
doi_str_mv | 10.1002/alr.22976 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2620081595</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2718526410</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3536-61eb10fea6c09e3d6c1df1ef7da3277d3d5929dccfd5f718c08693bcfefa0bfd3</originalsourceid><addsrcrecordid>eNp1kc9KJDEQh8Pisop68AUk4MU9jCbpSXr6KOI_mEUQPYd0UnGimaRN0sjcfIR9Rp_ErKMeFqxDKlR9fBT8ENqj5IgSwo6VT0eMda34gbYYmbKJ6GbTja9_KzbRbs4PpBannNP2F9psOGGV4ltodT2W15e_0dZniPoRCtYxl4yjxb2LPt47jUsCVZYQ6tjGhPUixVDHaeFCzC6M2RWX8bMrCxxUVh4P0a-GusrYBVwWgP-AcVolqJth9Kq4GHbQT6t8ht2Pvo3uzs9uTy8n8-uLq9OT-UQ3vBETQaGnxIISmnTQGKGpsRRsa1TD2tY0hnesM1pbw21LZ5rMRNf02oJVpLem2UaHa--Q4tMIucilyxq8VwHimCUTjJAZ5R2v6MF_6EMcU6jXSVbVnIkpJZX6vaZ0ijknsHJIbqnSSlIi_0UiayTyPZLK7n8Yx34J5ov8DKACx2vg2XlYfW-SJ_ObtfIN8ayaYQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2718526410</pqid></control><display><type>article</type><title>Out‐of‐pocket costs of biologic treatments for chronic rhinosinusitis with nasal polyposis in the Medicare population</title><source>Access via Wiley Online Library</source><creator>Rathi, Vinay K. ; Scangas, George A. ; Metson, Ralph B. ; Xiao, Roy ; Nshuti, Leonce ; Dusetzina, Stacie B.</creator><creatorcontrib>Rathi, Vinay K. ; Scangas, George A. ; Metson, Ralph B. ; Xiao, Roy ; Nshuti, Leonce ; Dusetzina, Stacie B.</creatorcontrib><identifier>ISSN: 2042-6976</identifier><identifier>EISSN: 2042-6984</identifier><identifier>DOI: 10.1002/alr.22976</identifier><identifier>PMID: 35029845</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>chronic rhinosinusitis ; dupilumab ; Medicare Part D ; mepolizumab ; Monoclonal antibodies ; nasal polyposis ; omalizumab ; out‐of‐pocket ; Polyposis ; Rhinitis ; Rhinosinusitis ; Sinusitis</subject><ispartof>International forum of allergy & rhinology, 2022-10, Vol.12 (10), p.1295-1298</ispartof><rights>2022 ARS‐AAOA, LLC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3536-61eb10fea6c09e3d6c1df1ef7da3277d3d5929dccfd5f718c08693bcfefa0bfd3</citedby><cites>FETCH-LOGICAL-c3536-61eb10fea6c09e3d6c1df1ef7da3277d3d5929dccfd5f718c08693bcfefa0bfd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Falr.22976$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Falr.22976$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27929,27930,45579,45580</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35029845$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rathi, Vinay K.</creatorcontrib><creatorcontrib>Scangas, George A.</creatorcontrib><creatorcontrib>Metson, Ralph B.</creatorcontrib><creatorcontrib>Xiao, Roy</creatorcontrib><creatorcontrib>Nshuti, Leonce</creatorcontrib><creatorcontrib>Dusetzina, Stacie B.</creatorcontrib><title>Out‐of‐pocket costs of biologic treatments for chronic rhinosinusitis with nasal polyposis in the Medicare population</title><title>International forum of allergy & rhinology</title><addtitle>Int Forum Allergy Rhinol</addtitle><subject>chronic rhinosinusitis</subject><subject>dupilumab</subject><subject>Medicare Part D</subject><subject>mepolizumab</subject><subject>Monoclonal antibodies</subject><subject>nasal polyposis</subject><subject>omalizumab</subject><subject>out‐of‐pocket</subject><subject>Polyposis</subject><subject>Rhinitis</subject><subject>Rhinosinusitis</subject><subject>Sinusitis</subject><issn>2042-6976</issn><issn>2042-6984</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp1kc9KJDEQh8Pisop68AUk4MU9jCbpSXr6KOI_mEUQPYd0UnGimaRN0sjcfIR9Rp_ErKMeFqxDKlR9fBT8ENqj5IgSwo6VT0eMda34gbYYmbKJ6GbTja9_KzbRbs4PpBannNP2F9psOGGV4ltodT2W15e_0dZniPoRCtYxl4yjxb2LPt47jUsCVZYQ6tjGhPUixVDHaeFCzC6M2RWX8bMrCxxUVh4P0a-GusrYBVwWgP-AcVolqJth9Kq4GHbQT6t8ht2Pvo3uzs9uTy8n8-uLq9OT-UQ3vBETQaGnxIISmnTQGKGpsRRsa1TD2tY0hnesM1pbw21LZ5rMRNf02oJVpLem2UaHa--Q4tMIucilyxq8VwHimCUTjJAZ5R2v6MF_6EMcU6jXSVbVnIkpJZX6vaZ0ijknsHJIbqnSSlIi_0UiayTyPZLK7n8Yx34J5ov8DKACx2vg2XlYfW-SJ_ObtfIN8ayaYQ</recordid><startdate>202210</startdate><enddate>202210</enddate><creator>Rathi, Vinay K.</creator><creator>Scangas, George A.</creator><creator>Metson, Ralph B.</creator><creator>Xiao, Roy</creator><creator>Nshuti, Leonce</creator><creator>Dusetzina, Stacie B.</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>202210</creationdate><title>Out‐of‐pocket costs of biologic treatments for chronic rhinosinusitis with nasal polyposis in the Medicare population</title><author>Rathi, Vinay K. ; Scangas, George A. ; Metson, Ralph B. ; Xiao, Roy ; Nshuti, Leonce ; Dusetzina, Stacie B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3536-61eb10fea6c09e3d6c1df1ef7da3277d3d5929dccfd5f718c08693bcfefa0bfd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>chronic rhinosinusitis</topic><topic>dupilumab</topic><topic>Medicare Part D</topic><topic>mepolizumab</topic><topic>Monoclonal antibodies</topic><topic>nasal polyposis</topic><topic>omalizumab</topic><topic>out‐of‐pocket</topic><topic>Polyposis</topic><topic>Rhinitis</topic><topic>Rhinosinusitis</topic><topic>Sinusitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rathi, Vinay K.</creatorcontrib><creatorcontrib>Scangas, George A.</creatorcontrib><creatorcontrib>Metson, Ralph B.</creatorcontrib><creatorcontrib>Xiao, Roy</creatorcontrib><creatorcontrib>Nshuti, Leonce</creatorcontrib><creatorcontrib>Dusetzina, Stacie B.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>International forum of allergy & rhinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rathi, Vinay K.</au><au>Scangas, George A.</au><au>Metson, Ralph B.</au><au>Xiao, Roy</au><au>Nshuti, Leonce</au><au>Dusetzina, Stacie B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Out‐of‐pocket costs of biologic treatments for chronic rhinosinusitis with nasal polyposis in the Medicare population</atitle><jtitle>International forum of allergy & rhinology</jtitle><addtitle>Int Forum Allergy Rhinol</addtitle><date>2022-10</date><risdate>2022</risdate><volume>12</volume><issue>10</issue><spage>1295</spage><epage>1298</epage><pages>1295-1298</pages><issn>2042-6976</issn><eissn>2042-6984</eissn><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>35029845</pmid><doi>10.1002/alr.22976</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2042-6976 |
ispartof | International forum of allergy & rhinology, 2022-10, Vol.12 (10), p.1295-1298 |
issn | 2042-6976 2042-6984 |
language | eng |
recordid | cdi_proquest_miscellaneous_2620081595 |
source | Access via Wiley Online Library |
subjects | chronic rhinosinusitis dupilumab Medicare Part D mepolizumab Monoclonal antibodies nasal polyposis omalizumab out‐of‐pocket Polyposis Rhinitis Rhinosinusitis Sinusitis |
title | Out‐of‐pocket costs of biologic treatments for chronic rhinosinusitis with nasal polyposis in the Medicare population |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T22%3A12%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Out%E2%80%90of%E2%80%90pocket%20costs%20of%20biologic%20treatments%20for%20chronic%20rhinosinusitis%20with%20nasal%20polyposis%20in%20the%20Medicare%20population&rft.jtitle=International%20forum%20of%20allergy%20&%20rhinology&rft.au=Rathi,%20Vinay%20K.&rft.date=2022-10&rft.volume=12&rft.issue=10&rft.spage=1295&rft.epage=1298&rft.pages=1295-1298&rft.issn=2042-6976&rft.eissn=2042-6984&rft_id=info:doi/10.1002/alr.22976&rft_dat=%3Cproquest_cross%3E2718526410%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2718526410&rft_id=info:pmid/35029845&rfr_iscdi=true |